This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stewart, W. E. Articles by Lockart, R. Z. Search for Related Content PubMed PubMed Citation Articles by Stewart, W. E., II Articles by Lockart, R. Z., Jr.

Priming: a Nonantiviral Function of Interferon ¹

^a Central Research Department, Experimental Station, E. I. du Pont de Nemours and Company, Wilmington, Delaware 19898

ABSTRACT

No interferon is made by L cells when they are infected with MM virus. However, several thousand units of interferon are produced when interferon-treated L cells are infected with MM virus. We call the conversion of cells, from nonproducers to producers, priming. The time required for cells to become fully primed is dependent on the interferon concentration with which they are incubated. Primed cells produced interferon earlier than normal cells stimulated by other inducers. Cells which were exposed to interferon in the presence of inhibitors of protein synthesis became fully primed yet developed no virus resistance. Also, primed cells produced interferon in response to low concentrations of polyriboinosinic acid · polyribocytidylic acid that did not induce interferon in normal cells. Therefore, priming appears to be a function of interferon separable from its antiviral activity. Several other picornaviruses that failed to induce interferon in L cells, human embryonic lung cells, or monkey kidney cells did induce interferon when these cells had been primed by homologous interferons.

¹ Contribution No. 1797.

This article has been cited by other articles:

• Yoshikawa, T., Iwasaki, T., Ida-Hosonuma, M., Yoneyama, M., Fujita, T., Horie, H., Miyazawa, M., Abe, S., Simizu, B., Koike, S. (2006). Role of the Alpha/Beta Interferon Response in the Acquisition of Susceptibility to Poliovirus by Kidney Cells in Culture. J. Virol. 80: 4313-4325 [Abstract] [Full Text]  
• Xu, D., Brumm, K., Zhang, L. (2006). The Latent Membrane Protein 1 of Epstein-Barr Virus (EBV) Primes EBV Latency Cells for Type I Interferon Production. J. Biol. Chem. 281: 9163-9169 [Abstract] [Full Text]  
• Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N., Taniguchi, T. (2000). Cross Talk Between Interferon-gamma and -alpha /beta Signaling Components in Caveolar Membrane Domains. Science 288: 2357-2360 [Abstract] [Full Text]  
• Carr, D. J. J., Veress, L. A., Noisakran, S., Campbell, I. L. (1998). Astrocyte-Targeted Expression of IFN-{alpha}1 Protects Mice from Acute Ocular Herpes Simplex Virus Type 1 Infection. J. Immunol. 161: 4859-4865 [Abstract] [Full Text]  
• Yeow, W.-S., Lawson, C. M., Beilharz, M. W. (1998). Antiviral Activities of Individual Murine IFN-{alpha} Subtypes In Vivo: Intramuscular Injection of IFN Expression Constructs Reduces Cytomegalovirus Replication. J. Immunol. 160: 2932-2939 [Abstract] [Full Text]